{"id":"https://openalex.org/W2009396173","doi":"https://doi.org/10.1309/lmwat6w5lt3tipvx","title":"Antibody-Based Immunotherapeutic Agents for Treatment of Non-Hodgkin Lymphoma","display_name":"Antibody-Based Immunotherapeutic Agents for Treatment of Non-Hodgkin Lymphoma","publication_year":2013,"publication_date":"2013-05-01","ids":{"openalex":"https://openalex.org/W2009396173","doi":"https://doi.org/10.1309/lmwat6w5lt3tipvx","mag":"2009396173"},"language":"en","primary_location":{"id":"doi:10.1309/lmwat6w5lt3tipvx","doi":"https://doi.org/10.1309/lmwat6w5lt3tipvx","is_oa":false,"landing_page_url":"https://doi.org/10.1309/lmwat6w5lt3tipvx","pdf_url":null,"source":{"id":"https://openalex.org/S19362967","display_name":"Laboratory Medicine","issn_l":"0007-5027","issn":["0007-5027","1943-7730"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Laboratory Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112904385","display_name":"Steven I. Park","orcid":"https://orcid.org/0000-0001-5674-6408","observed_orcids":["https://orcid.org/0000-0001-5674-6408"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven I. Park","raw_affiliation_strings":["Division of Hematology and Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054381821","display_name":"Kristy L. Richards","orcid":"https://orcid.org/0000-0001-5765-6631","observed_orcids":["https://orcid.org/0000-0001-5765-6631"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristy L. Richards","raw_affiliation_strings":["Division of Hematology and Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4535,"currency":"USD","value_usd":4535},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.10050351,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"44","issue":"2","first_page":"108","last_page":"113"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/antibody-based-immunotherapy","display_name":"antibody-based immunotherapy","score":0.9580000042915344},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9900000095367432},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.7870000004768372},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.699999988079071},{"id":"https://openalex.org/keywords/alemtuzumab","display_name":"alemtuzumab","score":0.734000027179718},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7099999785423279},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.8619999885559082}],"concepts":[{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5999796390533447},{"id":"https://openalex.org/C2992779791","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Hodgkin lymphoma","level":3,"score":0.5726233720779419},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5660532116889954},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.46786144375801086},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.41194993257522583},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3624503016471863},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3584447503089905},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3271023631095886},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.20370042324066162}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1309/lmwat6w5lt3tipvx","doi":"https://doi.org/10.1309/lmwat6w5lt3tipvx","is_oa":false,"landing_page_url":"https://doi.org/10.1309/lmwat6w5lt3tipvx","pdf_url":null,"source":{"id":"https://openalex.org/S19362967","display_name":"Laboratory Medicine","issn_l":"0007-5027","issn":["0007-5027","1943-7730"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Laboratory Medicine","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.4699999988079071,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320314458","display_name":"National Comprehensive Cancer Network","ror":"https://ror.org/0465x5x63"},{"id":"https://openalex.org/F4320322648","display_name":"Universit\u00e0 degli Studi di Firenze","ror":"https://ror.org/04jr1s763"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2099649432","https://openalex.org/W170766043","https://openalex.org/W2100118076","https://openalex.org/W2115658527","https://openalex.org/W1983330474","https://openalex.org/W2021812388","https://openalex.org/W2133920177","https://openalex.org/W2164484724","https://openalex.org/W2398305833","https://openalex.org/W2426455839"],"abstract_inverted_index":{"Antibody-based":[0],"immunotherapeutic":[1,113],"agents":[2,19,114],"have":[3,72],"emerged":[4],"as":[5,67,69],"important":[6],"treatment":[7,85,116,137],"options":[8],"for":[9,84,115,131,136],"non-Hodgkin":[10,40,60,87,118,142,165],"lymphoma.":[11,41,61,88],"Recent":[12],"data":[13],"suggest":[14],"that":[15,93],"use":[16,133],"of":[17,57,86,117,134,138,141,622,635],"these":[18],"not":[20,662,674],"only":[21],"induces":[22],"high":[23],"response":[24],"rates":[25],"but":[26],"also":[27],"results":[28],"in":[29,37,100,120],"improved":[30],"survival":[31],"when":[32],"combined":[33],"with":[34,39,59],"conventional":[35],"chemotherapy":[36],"patients":[38,58],"As":[42],"a":[43],"result,":[44],"antibody-based":[45,112],"immunotherapy":[46],"has":[47],"changed":[48],"lymphoma":[49,119],"therapy":[50],"considerably":[51],"and":[52,64,80,102,124,128,232,284,348,362,452,506,650,690],"dramatically":[53],"impacted":[54],"the":[55,76,108,132],"management":[56],"Several":[62],"unmodified":[63],"radiolabeled":[65],"antibodies,":[66],"well":[68],"antibody-drug":[70],"conjugates,":[71],"been":[73],"approved":[74],"by":[75],"United":[77,281],"States":[78,282],"Food":[79,283],"Drug":[81,285],"Administration":[82],"(FDA)":[83],"Also,":[89],"more":[90],"promising":[91],"antibodies":[92,135],"target":[94],"other":[95],"epitopes":[96],"are":[97],"being":[98],"developed":[99],"preclinical":[101],"clinical":[103,122,127],"studies.":[104],"This":[105],"review":[106],"presents":[107],"latest":[109],"information":[110],"on":[111],"various":[121],"settings":[123],"discusses":[125],"current":[126],"laboratory":[129],"guidelines":[130],"different":[139],"subtypes":[140],"lymphoma.\n\n*":[143],"IPIT\n":[146],":":[150,162,174,188,200,213,226,241,253,266,278,294,306,318,330,343,357,371,383,395,408,422,434,448,463,476,489,502,515,530,541,554,566,579,591,603,617,631,645,659,671,683],"individualized":[153],"therapy;\n":[154],"NHL\n":[158],"lymphoma;\n":[166,180,192,595,609],"DLBCL\n":[170],"diffuse":[177],"large":[178,607],"B-cell":[179],"FL\n":[184],"follicular":[191],"CLL\n":[196],"chronic":[203],"lymphocytic":[204,217],"leukemia;\n":[205,218,571],"SLL\n":[209],"small":[216],"CHOP\n":[222],"cyclophosphamide,":[229,346,689],"doxorubicin,":[230,688],"vincristine,":[231,347],"prednisone;\n":[233,349,363],"MoAbs\n":[237],"monoclonal":[244],"antibodies;\n":[245],"ADCC\n":[249],"antibody-dependent":[256],"cellular":[257],"cytotoxicity;\n":[258,270],"CDC\n":[262],"complement-dependent":[269],"FDA\n":[274],"Administration;\n":[286],"RIT\n":[290],"radioimmunotherapy;\n":[297],"IL-2":[301],"interleukin":[309],"2;\n":[310],"OR\n":[314],"overall":[321,374],"response;\n":[322,426],"TTP\n":[326],"time":[333],"to":[334],"progression;\n":[335],"CVP\n":[339],"MCP\n":[353,641],"mitoxantrone,":[360,648],"chlorambucil,":[361,649],"OS\n":[367],"survival;\n":[375,387],"PFS\n":[379],"progression-free":[386],"R-CHOP\n":[391],"rituximab":[398],"plus":[399,480,493,519,521],"CHOP;\n":[400],"NCCN\n":[404],"National":[411,620],"Comprehensive":[412],"Cancer":[413,451],"Network;\n":[414],"CR\n":[418],"complete":[425],"ECOG\n":[430],"Eastern":[437],"Cooperative":[438],"Oncology":[439],"Group;\n":[440],"CALGB\n":[444],"Leukemia":[453],"Group":[454],"B;\n":[455],"CNS\n":[459],"central":[466],"nervous":[467],"system;\n":[468],"FR\n":[472],"rituxamine":[479],"fludarabine;\n":[481],"FCR\n":[485,511],"fludarabine":[492,505,518],"cyclophosphamide;\n":[494,507],"FC\n":[498],"cyclophosphamide":[520],"rituximab;\n":[522],"CMV\n":[526],"cytomegalovirus;\n":[533],"PCR\n":[537],"polymerase":[544],"chain":[545],"reaction;\n":[546],"MDS\n":[550],"myelodysplastic":[557],"syndrome;\n":[558],"AML\n":[562],"acute":[569],"myeloid":[570],"tMDS/tAML\n":[575],"treatment-related":[582],"MDS/AML;\n":[583],"HL\n":[587],"Hodgkin":[594],"ALCL\n":[599],"anaplastic":[606],"cell":[608],"NIH\n":[613],"Institutes":[621],"Health;\n":[623],"UNC\n":[627],"University":[634],"North":[636],"Carolina;\n":[637],"prednisolone;\n":[651],"NA\n":[655],"available;\n":[663],"NR\n":[667],"reached;\n":[675],"ProMACE\n":[679],"prednisone,":[686],"methotrexate,":[687],"etoposide":[691]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}